Lexicon Pharmaceuticals, Inc. (LXRX)

Last Closing Price: 1.91 (2026-06-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Lexicon Pharmaceuticals, Inc. (LXRX) had Net Income of $-1.04M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$21.10M
Net Income
$-1.04M
$0.11M
$20.99M
$22.10M
$-1.00M
$-0.05M
$-1.04M
$-1.04M
$-1.04M
$-1.04M
$-1.04M
$-1.04M
$-1.00M
$-0.20M
400.24M
400.24M
$-0.00
$-0.00
Balance Sheet Financials
$186.03M
$1.75M
$82.79M
$268.82M
$9.90M
$49.68M
$56.06M
$65.96M
$202.85M
$158.31M
$202.86M
423.77M
Cash Flow Statement Financials
$-14.73M
$-70.26M
$88.76M
$63.33M
$67.09M
$3.76M
$3.08M
--
--
Fundamental Metrics & Ratios
18.79
--
--
0.20
0.24
99.49%
-4.72%
-4.72%
--
-4.94%
-4.94%
$-14.73M
--
--
--
0.08
0.39
1.79
50.24
-0.51%
-0.66%
-0.39%
-0.41%
$0.48
$-0.04
$-0.04